The authors declare that they have no competing interests.
KCC, SYS and CCP contributed to this work by designing the study, obtaining data, performing the statistical analysis, writing the manuscript and interpreted the data. CLH and KHS participated in the conception and design of the study and acquisition of data. RYP and YTL participated in the conception and design of the study and interpretation of the data and reviewed and edited the manuscript. All authors read and approved the final manuscript.
Both benign prostatic hyperplasia (BPH) and Type-1 diabetes mellitus (T1DM) share similar epidemiologic features and are all associated with the insulin-like growth factor (IGF)-mediated hormonal imbalance. The purpose of this study is to understand whether exercise (EX) could alleviate DM and DM + BPH.
Sprague-Dawley rats were divided into eight groups: normal control, EX, BPH, BPH + EX, DM, DM + EX, BPH + DM, and BPH + DM + EX. T1DM was induced by intraperitoneal (ip) injection of streptozotocin (65 mg/kg) in Week 2, and BPH was induced by successive ip injections of Sustanon® (testosterone, 3.5 mg/head) plus estradiol (0.1 mg/head) from Week 3 to Week 9. Treadmill exercise training (20 m/min, 60 min per time) was performed three times per week for 6 weeks.
In BPH + EX, EX maintained at a constant body weight (BW); and suppressed stromal layer thickening, collagen deposition, blood glucose (BG), levels of testosterone (Ts), 5α-reductase(5αRd), dihydrotestosterone (DHT), androgen receptor (AR), serum hydrogen peroxide, TBARs, and interleukin-6 (IL-6). EX recovered testes size and substantially increased nitric oxide (NO) levels. In DM + EX group, EX decreased BW, PW, nuclear proliferation, inflammatory cell aggregation, collagen deposition, and BG. As contrast, EX upregulated insulin, IGF, Ts, NO, 5αRd, AR, and DHT, and substantially reduced PSA. In BPH + DM + EX, EX maintained BW at a subnormal level, slightly suppressed prostate stromal inflammation, collagen deposition, and BG, moderately restored sIn and IGF. Although failed to suppress Ts, EX highly upregulated 5αRd and suppressed DHT and AR, together with highly upregulated NO resulting in substantially reduced PSA.
EX, by remodeling androgen and NO expressions, can effectively alleviate BPH, DM, and BPH + DM.
Zinman B, Ruderman N, Campaigne BN, Devlin JT, Schneider SH. Physical activity/exercise and Diabetes Mellitus. Diabetes care. 2003;26 Suppl 1:S73–7. PubMed
de Lemos ET, Oliveira J, Pinheiro JP, Reis F. Regular Physical Exercise as a Strategy to improve antioxidant and anti-Inflammatory status: Benefits in type 2 diabetes mellitus. Oxidative Med and Cellu Longevity. 2012;741545:1–15. CrossRef
Charnow JA. Exercise May Lower BPH, LUTS Risk. April 07, 2008, Renal & Urology News. ( http://www.renalandurologynews.com/exercise-may-lower-bph-luts-risk/article/108726/#).
Peng CC, Liu JH, Chang CH, Chung JY, Chen KC, Chou KY, et al. Action mechanism of Ginkgo biloba leaf extract intervened by exercise therapy in treatment of benign prostate hyperplasia. Evid Based Complement Alternat Med. 2013;408734:1–12. CrossRef
Sea J, Poon KS, McVary KT. Review of exercise and the risk of benign prostatic hyperplasia. Phys Sports med. 2009;37:75–83. CrossRef
Ronald JS, Glen PK, David HW, Carmen C-S, Russell DW. Physical Activity/Exercise and Type 2 Diabetes: A consensus statement from the American Diabetes Association. Diabetes Care. 2006;29:1433–8. CrossRef
Stamatiou K, Lardas M, Kostakos E, Koutsonasios V, Michail E. The impact of diabetes type 2 in the pathogenesis of benign prostatic hyperplasia: a review. Adv Urol. 2009;818965:1–3. CrossRef
Liu SH, Wang ZS. Study on the expression of androgen receptor in testis, epididymis and prostate of adult rats with diabetes. Zhonghua Nan Ke Xue. 2005;11:891–4. PubMed
Stamatiadis D, Bulteau-Portois MC, Mowszowicz I. Inhibition of 5 alpha-reductase activity in human skin by zinc and azelaic acid. The Brit J Dermat. 1988;119(5):627–32. CrossRef
Yahya H, Yahya KM, Saqib A. Minerals and type 2 diabetes mellitus –level of zinc, magnesium and chromium in diabetic and non diabetic population. J Univer Med & Dent College. 2011;2:34–8.
Dressendorfer RA, Sockolov R. Hypozincemia in runners. Phys Sports Med. 1980;8:97–100. CrossRef
Wierusz-Wysocka B, Wysocki H, Byks H, Zozulińska D, Wykretowicz A, Kaźmierczak M. Metabolic control quality and free radical activity in diabetic patients. Diabetes Res Clin Practice. 1995;27:193–7. CrossRef
Aryal M, Pandeya A, Gautam N, Baral N, Lamsal M, Majhi S, et al. Oxidative stress in benign prostate hyperplasia. Nepal Med Coll J. 2007;9:222–4. PubMed
Laaksonen DE, Sen CK. Exercise and Oxidative Stress in Diabetes Mellitus. In: Sen CK, Packer L, Hanninen O, editors. Handbook of Oxidants and Antioxidants in Exercise. Amsterdam: Elsevier; 2000. p. 1105–36. CrossRef
Okamoto M, Lee C, Oyasu R. Interleukin-6 as a paracrine and autocrine growth factor in human prostatic carcinoma cells in vitro. Cancer Res. 1997;57:141–6. PubMed
- Benign prostatic hyperplasia complicated with T1DM can be alleviated by treadmill exercise—evidences revealed by the rat model
Robert Y. Peng
- BioMed Central
Neu im Fachgebiet Urologie
Meistgelesene Bücher in der Urologie
Mail Icon II